Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2000-4-11
pubmed:abstractText
Although whole-body hyperthermia combined with specific genotoxic chemotherapy can be shown to enhance neoplastic cell killing without a concomitant rise in bone marrow toxicity, nephrotoxicity can become treatment-limiting. This study compares the kidney toxicity to the kidney of ifosfamide, carboplatin and etoposide (ICE) chemotherapy alone, and ICE chemotherapy combined with either extracorporeal (e-WBH) or radiant-heat-induced hyperthermia (r-WBH) in 43 patients with refractory sarcoma. Within 3 days of ICE chemotherapy treatment there was a significant increase in urinary protein excretion and a reduction of the glomerular filtration rate. These effects were more pronounced if WBH was added. The use of immunoluminometric assays revealed a predominance of low-molecular-mass proteins. This increase in protein excretion persisted in the e-WBH-treated group, whereas it vanished within 3 weeks in both the group treated with ICE alone and that treated with r-WBH. Our findings suggest that ICE chemotherapy causes transient tubular and glomerular damage, which is enhanced by WBH. In terms of long-term nephrotoxicity e-WBH was more nephrotoxic than r-WBH. This finding is consistent with our clinical observations.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0171-5216
pubmed:author
pubmed:issnType
Print
pubmed:volume
126
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
173-7
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:10741912-Adolescent, pubmed-meshheading:10741912-Adult, pubmed-meshheading:10741912-Aged, pubmed-meshheading:10741912-Albuminuria, pubmed-meshheading:10741912-Antineoplastic Agents, Alkylating, pubmed-meshheading:10741912-Antineoplastic Agents, Phytogenic, pubmed-meshheading:10741912-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:10741912-Carboplatin, pubmed-meshheading:10741912-Clinical Trials, Phase II as Topic, pubmed-meshheading:10741912-Creatinine, pubmed-meshheading:10741912-Etoposide, pubmed-meshheading:10741912-Female, pubmed-meshheading:10741912-Glomerular Filtration Rate, pubmed-meshheading:10741912-Glycoproteins, pubmed-meshheading:10741912-Humans, pubmed-meshheading:10741912-Hyperthermia, Induced, pubmed-meshheading:10741912-Ifosfamide, pubmed-meshheading:10741912-Immunoglobulin G, pubmed-meshheading:10741912-Kidney, pubmed-meshheading:10741912-Male, pubmed-meshheading:10741912-Membrane Glycoproteins, pubmed-meshheading:10741912-Middle Aged, pubmed-meshheading:10741912-Sarcoma, pubmed-meshheading:10741912-Trypsin Inhibitor, Kunitz Soybean
pubmed:year
2000
pubmed:articleTitle
Nephrotoxicity of ifosfamide, carboplatin and etoposide (ICE) alone or combined with extracorporeal or radiant-heat-induced whole-body hyperthermia.
pubmed:affiliation
Department of Internal Medicine I, Medical University of Lübeck, Germany. gerke@hotmail.com
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't